First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Sees Large Increase in Short Interest

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) saw a large increase in short interest in January. As of January 31st, there was short interest totalling 1,200 shares, an increase of 33.3% from the January 15th total of 900 shares. Based on an average daily trading volume, of 2,900 shares, the days-to-cover ratio is presently 0.4 days.

Institutional Trading of First Trust Nasdaq Pharmaceuticals ETF

A number of institutional investors and hedge funds have recently modified their holdings of the company. Envestnet Asset Management Inc. grew its stake in shares of First Trust Nasdaq Pharmaceuticals ETF by 17.0% in the 4th quarter. Envestnet Asset Management Inc. now owns 16,403 shares of the company’s stock valued at $442,000 after purchasing an additional 2,384 shares during the period. Ameritas Investment Partners Inc. raised its holdings in First Trust Nasdaq Pharmaceuticals ETF by 13.0% during the 4th quarter. Ameritas Investment Partners Inc. now owns 14,173 shares of the company’s stock worth $382,000 after purchasing an additional 1,633 shares during the last quarter. Finally, LPL Financial LLC lifted its stake in shares of First Trust Nasdaq Pharmaceuticals ETF by 9.3% in the 4th quarter. LPL Financial LLC now owns 55,876 shares of the company’s stock valued at $1,507,000 after purchasing an additional 4,776 shares during the period.

First Trust Nasdaq Pharmaceuticals ETF Trading Down 1.4 %

NASDAQ FTXH traded down $0.38 during trading on Friday, reaching $27.25. The company’s stock had a trading volume of 455 shares, compared to its average volume of 3,332. The stock has a market capitalization of $13.63 million, a PE ratio of 15.98 and a beta of 0.70. First Trust Nasdaq Pharmaceuticals ETF has a 1-year low of $25.73 and a 1-year high of $29.72. The business has a 50-day moving average price of $27.31 and a 200-day moving average price of $28.15.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The business also recently declared a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Friday, December 13th were issued a $0.1304 dividend. The ex-dividend date was Friday, December 13th. This is an increase from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.